NCT05943067View on ClinicalTrials.gov

CD45RA Depleted DLI After TCRα/β Depleted Haploidentical HCT

PHASE1/PHASE2RecruitingINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

April 27, 2023

Primary Completion Date

January 31, 2028

Study Completion Date

December 31, 2028

Conditions
Hematologic Malignancy
Interventions
BIOLOGICAL

CD45RA depleted donor lymphocyte infusion (DLI)

CD45RA depleted donor lymphocyte infusion (DLI) after TCRα/β depleted haploidentical HCT

Trial Locations (2)

72076

RECRUITING

University Children's Hospital University Clinic Tuebingen, Tübingen

RECRUITING

University Hospital Tuebingen, Department of Hematology, Oncology, Immunology and Rheumatology, Tübingen

All Listed Sponsors
lead

University Hospital Tuebingen

OTHER